208 related articles for article (PubMed ID: 11292752)
1. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
[TBL] [Abstract][Full Text] [Related]
2. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
[TBL] [Abstract][Full Text] [Related]
3. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
4. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.
Cripps AW; Dunkley ML; Clancy RL
Infect Immun; 1994 Apr; 62(4):1427-36. PubMed ID: 8132349
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
6. The protective role of pulmonary neutrophils in rats intestinally immunized with Pseudomonas aeruginosa.
Buret A; Dunkley M; Clancy RL; Cripps AW
Adv Exp Med Biol; 1995; 371B():765-9. PubMed ID: 7502894
[No Abstract] [Full Text] [Related]
7. [Local immunization against P. aeruginosa with an outer-membrane-protein vaccine].
Grundmann T; Freihorst J; Kubesch P; Tümmler B; von der Hardt H
Pneumologie; 1991 Nov; 45(11):924-7. PubMed ID: 1763004
[TBL] [Abstract][Full Text] [Related]
8. Immunity to Pseudomonas aeruginosa induced by OprF following intestinal immunization.
Cripps AW; Dunkley ML; Taylor DC; Cousins S; Clancy RL
Adv Exp Med Biol; 1995; 371B():761-3. PubMed ID: 7502893
[No Abstract] [Full Text] [Related]
9. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
10. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
Johansen HK; Høiby N; Pedersen SS
APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
[TBL] [Abstract][Full Text] [Related]
11. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.
Buret A; Dunkley ML; Pang G; Clancy RL; Cripps AW
Infect Immun; 1994 Dec; 62(12):5335-43. PubMed ID: 7960112
[TBL] [Abstract][Full Text] [Related]
13. The immune system in experimental Pseudomonas keratitis. Model and early effects.
Twining SS; Lohr KM; Moulder JE
Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789
[TBL] [Abstract][Full Text] [Related]
14. Oral vaccination and multivalent vaccine against Pseudomonas aeruginosa keratitis.
Gerke JR; Nelson JS
Invest Ophthalmol Vis Sci; 1977 Jan; 16(1):76-80. PubMed ID: 832968
[TBL] [Abstract][Full Text] [Related]
15. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
16. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.
Steuhl KP; Döring G; Henni A; Thiel HJ; Botzenhart K
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.
Homma JY; Abe C; Tanamoto K; Hirao Y; Morihara K; Tsuzuki H; Yanagawa R; Honda E; Aoi Y; Fujimoto Y; Goryo M; Imazeki N; Noda H; Goda A; Takeuchi S; Ishihara T
Jpn J Exp Med; 1978 Apr; 48(2):111-33. PubMed ID: 101698
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of the lung following intratracheal challenge with live Pseudomonas aeruginosa in intestinally immunized rats.
Wilson NR; Dunkley ML; Buret A; Young B; Cripps AW
Immunol Cell Biol; 1995 Oct; 73(5):440-5. PubMed ID: 8595922
[TBL] [Abstract][Full Text] [Related]
20. [The significance of bacterial and host factors in corneal infections caused by Pseudomonas aeruginosa].
Steuhl KP; Döring G; Thiel HJ
Fortschr Ophthalmol; 1989; 86(4):283-6. PubMed ID: 2507425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
